These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 1913071)

  • 1. Surgery following chemotherapy for metastatic testicular teratoma.
    Whillis D; Coleman RE; Lessells AM; Hargreave TB; Cornbleet MA; Howard GC
    Br J Urol; 1991 Sep; 68(3):292-5. PubMed ID: 1913071
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Failure of salvage treatment in metastatic testicular teratoma.
    Whillis D; Coleman RE; Cornbleet MA; Howard GC
    Clin Oncol (R Coll Radiol); 1991 May; 3(3):141-6. PubMed ID: 1712626
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Excision of residual masses after platinum based chemotherapy for non-seminomatous germ cell tumours.
    Harding MJ; Brown IL; MacPherson SG; Turner MA; Kaye SB
    Eur J Cancer Clin Oncol; 1989 Dec; 25(12):1689-94. PubMed ID: 2561098
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Survival after an antiangiogenetic therapy and surgery in a wide spread growing teratoma originating from a testicular mixed malignant germ cell tumor.
    Calaminus G; Schneider DT; Weissbach L; Schönberger S; Okpanyi V; Leuschner I; Poremba C; Göbel U
    Klin Padiatr; 2009; 221(3):136-40. PubMed ID: 19437360
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Persistent carcinoma in situ of the testis after chemotherapy for advanced testicular germ cell tumours.
    Bottomley D; Fisher C; Hendry WF; Horwich A
    Br J Urol; 1990 Oct; 66(4):420-4. PubMed ID: 2224437
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Excision of residual masses of metastatic germ cell tumours after chemotherapy: the role of extraperitoneal surgical approaches.
    Christmas TJ; Doherty AP; Rustin GJ; Seckl MJ; Newlands ES
    Br J Urol; 1998 Feb; 81(2):301-8. PubMed ID: 9488076
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Predictors of residual mass requiring surgical resection after chemotherapy of stage III testicular cancer. A prospective study.
    Javadpour N; Young JD
    Urology; 1992 Jul; 40(1):7-8. PubMed ID: 1320303
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prognosis after resection of residual masses following chemotherapy for metastatic nonseminomatous testicular cancer: a multivariate analysis.
    Steyerberg EW; Keizer HJ; Zwartendijk J; Van Rijk GL; Van Groeningen CJ; Habbema JD; Stoter G
    Br J Cancer; 1993 Jul; 68(1):195-200. PubMed ID: 8318413
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Early resection of residual tumor during cisplatin, vinblastine, bleomycin combination chemotherapy in stage III and bulky stage II nonseminomatous testicular cancer.
    Pizzocaro G; Salvioni R; Pasi M; Zanoni F; Milani A; Pilotti S; Monfardini S
    Cancer; 1985 Jul; 56(2):249-55. PubMed ID: 2408728
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Histology of tumor residuals following chemotherapy in patients with advanced nonseminomatous testicular cancer.
    Fosså SD; Aass N; Ous S; Høie J; Stenwig AE; Lien HH; Paus E; Kaalhus O
    J Urol; 1989 Nov; 142(5):1239-42. PubMed ID: 2478726
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Treatment of retroperitoneal residual tumor after PVB chemotherapy of nonseminomatous testicular tumors.
    Gelderman WA; Koops HS; Sleijfer DT; Oosterhuis JW; Oldhoff J
    Cancer; 1986 Oct; 58(7):1418-21. PubMed ID: 2427186
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Sequential resection of residual abdominal and thoracic masses after chemotherapy for metastatic non-seminomatous germ cell tumours.
    Gerl A; Clemm C; Schmeller N; Dienemann H; Weiss M; Kriegmair M; Löhrs U; Wilmanns W
    Br J Cancer; 1994 Nov; 70(5):960-5. PubMed ID: 7524606
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prognostic features of teratomas with malignant transformation: a clinicopathological study of 21 cases.
    Comiter CV; Kibel AS; Richie JP; Nucci MR; Renshaw AA
    J Urol; 1998 Mar; 159(3):859-63. PubMed ID: 9474169
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Chemotherapy of testicular cancer: 10-year experience.
    Ondrus D; Hornák M; Matoska J; Kausitz J; Belan V; Cársky S
    Neoplasma; 1993; 40(4):247-53. PubMed ID: 7505886
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Residual masses after successful chemotherapy for testicular carcinoma.
    Glowalla M
    AJR Am J Roentgenol; 1986 Jun; 146(6):1184-6. PubMed ID: 3486562
    [No Abstract]   [Full Text] [Related]  

  • 16. Editorial comment on: postchemotherapy retroperitoneal lymph node dissection in advanced germ cell tumors of the testis.
    Jacqmin D
    Eur Urol; 2008 Feb; 53(2):272-3. PubMed ID: 18045771
    [No Abstract]   [Full Text] [Related]  

  • 17. The changing role of surgery in metastatic non-seminomatous germ cell tumour.
    Cassidy J; Lewis CR; Kaye SB; Kirk D
    Br J Cancer; 1992 Jan; 65(1):127-9. PubMed ID: 1370759
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Teratoma following cisplatin-based combination chemotherapy for nonseminomatous germ cell tumors: a clinicopathological correlation.
    Loehrer PJ; Hui S; Clark S; Seal M; Einhorn LH; Williams SD; Ulbright T; Mandelbaum I; Rowland R; Donohue JP
    J Urol; 1986 Jun; 135(6):1183-9. PubMed ID: 2423708
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Editorial comment on: postchemotherapy retroperitoneal lymph node dissection in advanced germ cell cancer tumors of the testis.
    Culine S
    Eur Urol; 2008 Feb; 53(2):273-4. PubMed ID: 18045772
    [No Abstract]   [Full Text] [Related]  

  • 20. Metastatic nonseminomatous germ cell tumors of the testis: results of elective and salvage surgery for patients with residual retroperitoneal masses.
    Hendry WF; Norman AR; Dearnaley DP; Fisher C; Nicholls J; Huddart RA; Horwich A
    Cancer; 2002 Mar; 94(6):1668-76. PubMed ID: 11920527
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.